Page last updated: 2024-11-04

sulfasalazine and Kidney Neoplasms

sulfasalazine has been researched along with Kidney Neoplasms in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, X1
Olszewski, K1
Zhang, Y1
Lim, EW1
Shi, J1
Zhang, X1
Zhang, J1
Lee, H1
Koppula, P1
Lei, G1
Zhuang, L1
You, MJ1
Fang, B1
Li, W1
Metallo, CM1
Poyurovsky, MV1
Gan, B1

Other Studies

1 other study available for sulfasalazine and Kidney Neoplasms

ArticleYear
Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
    Nature cell biology, 2020, Volume: 22, Issue:4

    Topics: Amino Acid Transport System y+; Animals; Biological Transport; Carcinoma, Renal Cell; Cell Death; Ce

2020